pramipexole has been researched along with Endocarditis, Loeffler in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archibald, DG; Bozik, ME; Brown, T; Dunbar, CE; Dworetzky, SI; Fay, MP; Hebrank, GT; Khoury, P; Klion, AD; Makiya, M; Maric, I; Panch, SR; Prussin, C; Sullivan, M; Sun, X; Ware, J; Wetzler, L | 1 |
| Gleich, GJ | 1 |
| Archibald, DG; Bozik, ME; Dworetzky, SI; Farwell, W; Hebrank, GT; Reynolds, IJ | 1 |
1 trial(s) available for pramipexole and Endocarditis, Loeffler
| Article | Year |
|---|---|
The targeted eosinophil-lowering effects of dexpramipexole in clinical studies.
Topics: Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Eosinophilia; Eosinophils; Humans; Hypereosinophilic Syndrome; Infections; Leukocyte Count; Pramipexole | 2017 |
2 other study(ies) available for pramipexole and Endocarditis, Loeffler
| Article | Year |
|---|---|
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.
Topics: Administration, Oral; Adult; Aged; Antioxidants; Eosinophils; Female; Follow-Up Studies; Humans; Hypereosinophilic Syndrome; Male; Middle Aged; Pramipexole; Prognosis; Safety; Steroids | 2018 |
Dexpramipexole: a new antieosinophil drug?
Topics: Benzothiazoles; Humans; Hypereosinophilic Syndrome; Pramipexole; Steroids | 2018 |